Needham Reiterates Inozyme Pharma (INZY) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on September 27, 2023, Needham reiterated coverage of Inozyme Pharma (NASDAQ:INZY) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-96957975-d7715708f50f494a8793a271fa91896c.jpg "5 Simple Investing Moves Warren Buffett Has Used to Become a Billionaire")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1692354788-189c05385e954c768fa92b72852f12fe.jpg "What Countries Have the Largest Gold Reserves?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1441906670-737751e94de8423696a20591523319bd.jpg "Where Presidential Candidates Get Campaign Funding")